Blinded sample size recalculation in randomized controlled trials with analysis of covariance
Biometrics · 01.07.2026 · 82 (3)
DOI: 10.1093/biomtc/ujag147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, online erschienen am 20.08.2026. Verfasst von Takumi Kanata und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Models, Statistical. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Work-Life Balance in Academia: A Career Skills Course for Researchers, Center for Coproduction of Inclusion, Diversity and Equity.
Abstract (Originalsprache)
In randomized controlled trials, covariate adjustment can improve statistical power and reduce the required sample size compared with unadjusted estimators. Analysis of covariance (ANCOVA) is often used to adjust for baseline covariates when outcomes are continuous. To design a sample size based on ANCOVA, it is necessary to prespecify the association between the outcome and baseline covariates, as well as among the baseline covariates themselves. However, determining these parameters at the design stage is challenging. Although it may be possible to adaptively assess these during the trial and recalculate the required sample size, existing sample size recalculation methods assume that the joint distribution of the outcome and baseline covariates is multivariate normal, which is not always the case in practice. In this study, we propose a blinded sample size recalculation method for the ANCOVA estimator based on the asymptotic relative efficiency under minimal distributional assumptions, thus accommodating arbitrary model misspecification. The proposed method is able to achieve the nominal power and reduce the required sample size without inflating the type I error rate in the final analysis. We conducted simulations to evaluate the performance of the proposed method under various scenarios. Applied to an HIV clinical trial, the proposed method reduced the required sample size by up to one-third compared to the unadjusted analysis, despite occasional slight increases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
- Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
- Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo 113-0033, Japan.
ORCID-Profile: Takumi Kanata, Yasuhiro Hagiwara
Förderung
- Work-Life Balance in Academia: A Career Skills Course for Researchers
- Center for Coproduction of Inclusion
- Diversity and Equity
- The University of Tokyo
Zitieren
APA
Kanata, T., Hagiwara, Y., & Oba, K. (2026). Blinded sample size recalculation in randomized controlled trials with analysis of covariance. Biometrics, 82(3). https://doi.org/10.1093/biomtc/ujag147
Vancouver
Kanata T, Hagiwara Y, Oba K. Blinded sample size recalculation in randomized controlled trials with analysis of covariance. Biometrics. 2026;82(3). doi:10.1093/biomtc/ujag147
BibTeX
@article{Kanata2026,
author = {Kanata, Takumi and Hagiwara, Yasuhiro and Oba, Koji},
title = {Blinded sample size recalculation in randomized controlled trials with analysis of covariance},
journal = {Biometrics},
year = {2026},
volume = {82},
number = {3},
doi = {10.1093/biomtc/ujag147}
}
EUVIMED